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aBstraCt
This is a case report of one patient who was diagnosed with microbial keratitis caused by staphylococcus MRSA. 
Its characteristics, etiology and symptoms will be described below. Moreover, we will discuss the clinical features, 
treatment plan and treatment outcome on our patient. 
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introduCtion
Methicillin-resistant Staphylococcus aureus (MRSA) 
is a form of contagious bacterial infection that is 
resistant to numerous antibiotics including methicil-
lin, amoxicillin, penicillin, and oxacillin. This resist-
ance makes it challenging to treat [1]. Methicillin is 
an antibiotic related to penicillin; it was once effec-
tive against staphylococci (staph), a type of bacteria. 
Staph bacteria have since developed a resistance to 
penicillin-related antibiotics, including methicillin. 
These resistant bacteria are called methicillin-re-
sistant staphylococcus aureus, or MRSA. If staph 
MRSA is diagnosed, its treatment will vary depend-
ing on a lot of factors, such as the type of infection, 
the location of infection, the severity of symptoms 
and the antibiotics to which the strain of MRSA 
responds [2]. Medication options for MRSA skin 
and soft tissue infections may include clindamycin, 
doxycycline, minocycline, trimethoprim and sulfam-
ethoxazole; rifampin and linezolid are treatment op-
tions for MRSA skin and soft tissue infections. Sta-
phylococcus aureus (MRSA) may severely infect the 
eye including the cornea, the anterior chamber and 
the vitreous body. Microbial keratitis and endoph-
thalmitis due to staph MRSA are vision-threatening 
infections and if not treated properly may result in 
severe loss of visual acuity or even blindness [3]. 
A case series of catastrophic eye infections caused by 
MRSA has been reported recently in patients after 
Lasik and cataract surgery [4–7]. Microbial keratitis 
if not treated appropriately may lead to cornea per-
foration and endophthalmitis. 
Case report
A 72-year-old patient, who was functionally 
one-eyed, contacted us reporting redness and for-
eign body sensation in his left eye. As he lives on 
an island far away from our clinic, it was highly 
unlikely that he would come to the clinic soon 
enough. Thus, with the view to assisting him in the 
best possible way we prescribed moxifloxacin and 
urged him to contact an ophthalmologist on his 
island. The patient did not trust the local ophthal-
mologist’s diagnosis; therefore, he preferred to come 
and be examined in our clinic.  
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The case-history of this patient was that he 
had lost vision in his right eye in the past due to 
an unsuccessful surgery for the detachment of 
the retina. As he also suffered from type 2 dia-
betes, he had an inflammation in macula in his 
left eye. Thus, we administered injections with 
anti-VEGF factors on a regular basis. Moreo-
ver, he used a lens in his left eye, as the eye was 
aphakic after endocapsular cataract surgery many 
years ago. His visual acuity was NLP for the 
right eye and 20/40 for his left eye. In the past 
month, the patient had been treated with Sim-
brinza, Duotrav and Acetazolamide pills, as he 
had also developed increased eye pressure. The ex-
amination was indeed conducted four days later. 
The examination led to an urgent penetrating 
keratoplasty due to an extensive infection in the 
cornea. The patient was prescribed moxifloxacin 
to be used every hour one day before the surgery 
(Fig. 1). The next day penetrating keratoplasty 
was performed. During the surgery a terphina-
tion of 8.5 mm was used because the patient was 
aphakic. During the surgery, wash out of the 
anterior chamber was performed combined with 
limited anterior vitrectomy. Intraoperatively, we 
saw a grey mash on the posterior segment of the 
eye (Fig. 2) which was due to choroidal detach-
ment caused by severe inflammation. The host 
cornea was sent to microbiology lab. During the 
first post-operating days, the patient was admin-
istered antibiotics that covered both gram positive 
(moxifloxacin) and gram negative bacteria (ami-
kacin fortified drops) as well as fungi (voricona-
zole drops and orally). The results of the micro-
biological lab tests were negative, so we decided to 
send the lens and the lenses’ case he had used for 
the correction of aphakia for PCR. The surgery 
of the penetrating keratoplasty was successful. 
The patient was treated with both moxifloxacin 
and amikacin fortified drops, as we did not know 
what had originally caused the inflammation. We 
stopped this particular treatment when the micro-
biological laboratory where we had sent the lens 
informed us that they had found staphylococcus 
MRSA. His visual acuity for the next month was 
LP. One week after the surgery, the intraocular 
pressure was still under 10  mm Hg, and after 
a B-scanning we noticed that the inflammation 
had infected the pars plana, as the patient had 
a choroidal detachment due to severe inflamma-
tory reaction to microbial keratitis (Fig. 3).
We decided to increase the dose of methylpred-
nisolone we had already prescribed and to examine 
our patient once a week. One month later, the visual 
acuity of his left eye was 1/20. Through a B-scan-
ning examination, we saw that the serous choroidal 
detachment had already been cured (Fig. 4). 
Figure 1. The photograph of the eye we took just before the 
surgery of penetrating keratoplasty
Figure 2. The image we took after the surgery of penetrating 
keratoplasty was over
Figure 3. Choroidal detachment (Kissing choroidals)
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It has been six months since the operation was 
performed. Now, the patient has a visual acuity 
1/20 on his left eye and he is only using moxi-
floxacin on a regular basis.
disCussion
When the microbiological tests on the graft 
came as negative on account of moxifloxacin, we 
went on to send the lenses’ case for PCR, which 
turned out to be positive for MRSA. Staphylococ-
cus MRSA may bring on severe microbial kerati-
tis. It’s remarkable that during the first attempt to 
detect which microbe had caused the inflamma-
tion, the answers did not include Staphylococcus 
MRSA. Prior to the operation, there was no B-
scan in order to detect the choroidal detachment. 
The choroidal detachment was cured after the in-
creased dose of corticosteroids and moxifloxacin 
[8–10]. We treated these symptoms with Medrol 
in advance, and they were cured within twenty-five 
days. As a result, we have come to the conclusion 
that, regarding the choroidal detachment, it is pref-
erable to insist on the administration of cortisone 
before we proceed to an operation. [11] There was 
resistance of the Staphylococcus MRSA to moxi-
floxacin or vancomycin.
Community-associated MRSA (CA-MRSA) 
is becoming increasingly prevalent, and ophthal-
mologists will see more ophthalmic MRSA infec-
tions. Although ophthalmic CA-MRSA commonly 
presents as preseptal lid infection and conjunctivitis, 
sight-threatening infections also occur. Ophthal-
mologists must identify MRSA patients, adjust em-
pirical treatment regimens where MRSA is endemic, 
and take steps to control emergence of resistant or-
ganisms in both inpatient and outpatient practices 
[12, 13]. Three of the five patients with MRSA kera-
titis had nosocomial infection. In all but one, effec-
tive antibiotic coverage was initiated empirically. 
That patient had atopic dermatitis with a history of 
shield ulcers bilaterally and was administered cipro-
floxacin ophthalmic drops as therapy initiation. The 
isolate proved resistant to both levofloxacin and cip-
rofloxacin. Of the other patients, two had a history 
of cocaine use (one with definite crack keratopathy), 
one had preceding herpes zoster ophthalmicus after 
decompressive craniotomy for intraparenchymal he-
matoma due to motor vehicle collision, and one suf-
fered trauma to the eye when a container of medical 
waste exploded. The latter patient was considered to 
have nosocomial infection, and the MRSA isolate 
had reduced susceptibility to levofloxacin and resist-
ance to tetracycline [14–16]. 
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Figure 4. B-scanning image a month after the surgery.  
The choroid is totally cured
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